← European Medicine Shortage Tracker · all medicines

olanzapine (pamoate d') monohydraté] [MAJ shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

olanzapine (pamoate d') monohydraté] [MAJ currently has availability issues reported in 1 European register: France.

Limited availability  ATC — · also listed as: olanzapine (pamoate d') monohydraté] [MAJ · data refreshed 12 November 2026

Key facts

As of 12 November 2026, 1 of the 10 tracked registers list current availability issues for olanzapine (pamoate d') monohydraté] [MAJ, covering 1 affected product presentation. The longest-running open report was filed in France on 2026-08-25 and has now been open for about 3 months.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇫🇷 FranceLimited availability
Zypadhera 210 mg, poudre et solvant pour suspension injectable à libération prolongée
2026-08-25—Psychiatrieregister ↗

Full report history (1 register entry)

Every individual register entry for olanzapine (pamoate d') monohydraté] [MAJ in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇫🇷 FRZypadhera 210 mg, poudre et solvant pour suspension injectable à libérLimited availability2026-08-25—Psychiatrie

Frequently asked

Is olanzapine (pamoate d') monohydraté] [MAJ currently in shortage in Europe?

Yes. As of 12 November 2026, availability issues are reported in: France. Availability is national — a shortage in one country does not mean it is short everywhere.

Where does this olanzapine (pamoate d') monohydraté] [MAJ availability data come from?

Directly from the official medicines-agency register that lists olanzapine (pamoate d') monohydraté] [MAJ: ANSM (France). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of olanzapine (pamoate d') monohydraté] [MAJ — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/olanzapine-pamoate-d-monohydrate-maj/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="olanzapine (pamoate d') monohydraté] [MAJ availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/olanzapine-pamoate-d-monohydrate-maj/">olanzapine (pamoate d') monohydraté] [MAJ shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “olanzapine (pamoate d') monohydraté] [MAJ: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 12 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.